Novaliq submits New Drug Application seeking approval for first-of-a-kind Dry Eye Disease Treatment CyclASol® : vimarsana.com

/PRNewswire/ -- Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free...

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Heidelberg , Baden Wüberg , Germany , United States , Netherlands , Holland , Americans , Christian Roesky , Mathias Hothum , Novaliq Gmb , Prnewswire Novaliq , Simone Angstmann Mehr , Clin Ophthalmol , Gmbh Co , Drug Administration , Novaliq Inc , Cornea Clinical Committee , Health Sciences , New Drug Application , Hopp Biotech , Dry Eye , Eye Products Market Report , Clinical Committee , Cataract Refract , Dry Eye Disease , Randomized Phase , Clinical Phase , Assess Efficacy , Waterfree Cyclosporine Formulation , Media Contact , Novaliq Gmbh ,